Diffusion-weighted MRI of hepatic tumor in rats: Comparison between in vivo and postmortem imaging acquisitions

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 3, 2009, Pages 621-628

  Sun, Xihe ^a,b   Wang, Huaijun ^a   Chen, Feng ^a   De Keyzer, Frederik ^a   Yu, Jie ^a   Jiang, Yansheng ^a   Feng, Yuanbo ^a   Li, Junjie ^a   Marchal, Guy ^a   Ni, Yicheng ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b SOUTHEAST UNIVERSITY   (China)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Animal; liver; Diffusion weighted imaging; DWI; In vivo; Postmortem; Tumor

Indexed keywords

COMBRETASTATIN A4 PHOSPHATE; GADODIAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EX VIVO STUDY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMAGE QUALITY; IMPLANTATION; IN VIVO STUDY; LIVER NECROSIS; LIVER TUMOR; MALE; MICROANGIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; RHABDOMYOSARCOMA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CONTRAST MEDIA; DIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NECROSIS; PHANTOMS, IMAGING; RATS; RATS, WISTAR; RHABDOMYOSARCOMA; STILBENES;

EID: 63449129265     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21675     Document Type: Article

References (35)

1. Le Bihan D, Poupon C, Amadon A, et al. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006;24:478-488.
2. Moffat BA, Hall DE, Stojanovska J, et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 2004;17:249-259.
3. Koh D-M, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188;1622-1635.
4. Deng J, Rhee TK, Sato KT, et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 2006;41:410-414.
5. Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 2003;181:708- 710.
6. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036.
7. Ross BD, Moffat BA, Lawrence TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2003;2:581-587.
8. Chen G, Horsman MR, Pedersen M, et al. The effect ofcombretasta-tin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours. Acta Oncol 2008;47:1071-1076.
9. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003;56:958-965.
10. Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004;232:685-692.
11. Cui Y, Zhang X-P, Sun Y-S, et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248:894-900.
12. Chen F, De Keyzer F, Wang H, et al. Diffusion weighted imaging in small rodents using clinical MRI scanners. Methods 2007;43:12-20.
13. Wang H, Van de Putte M, Chen F, et al. Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology. Eur Radiol 2008;18:1422-1430.
14. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc In-tervRadiol 2000;11:1245-1255.
15. Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology1988;168:497-505.
16. de Crespigny AJ, Rother J, Beaulieu C, et al. Rapid monitoring of diffusion, DC potential, and blood oxygenation changes during global ischemia. Effects of hypoglycemia, hyperglycemia, and TTX.Stroke 1999;30:2212-2222.
17. Hoehn-Berlage M, Back T, Norris DG. Early changes in apparent diffusion coefficient of rat brain following total circulatory arrest.MAGMA1994;2:39-42.
18. Pierpaoli C, Alger JR, Righini A, et al. High temporal resolution diffusion MRI of global cerebral ischemia and reperfusion. J Cereb Blood FlowMetab 1996;16:892-905.
19. Bode MK, Ruohonen J, Nieminen MT, et al. Potential of diffusion imaging in brain tumors: a review. Acta Radiol 2006;47:585-594.
20. Tozer GM, Prise VE, Wilson J, et al. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. CancerRes 2001;61:6413-6422.
21. Prise VE, Honess DJ, Stratford MR, et al. The vascular response of tumor and normal tissues in the rat to the vascular targeting agent,combretastatin A-4-phosphate, at clinically relevant doses. Int J Oncol 2002;21:717-726.
22. Wang H, Sun X, Chen F, et al. Treatment of rodent liver tumor with Combretastatin A4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology. Invest Radiol 2009 (in press).
23. Landuyt W, Ahmed B, Nuyts S, et al. In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment. Int J Radiat Oncol Biol Phys 2001;49:443-450.
24. Galbraith SM, Maxwell RJ, Lodge MA, et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol 2003;21:2831-2842.
25. Thoeny HC, De Keyzer F, Chen F, et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 2005;234:756-764.
26. Hermens AF, Barendsen GW. Cellular proliferation patterns in an experimental rhabdomyosarcoma in the rat. Eur J Cancer 1967;3:361-369.
27. Chen F, Sun X, De Keyzer F, et al. Liver tumor model with implanted rhabdomyosarcoma in rats: MR imaging, microangiography, and histopathologic analysis. Radiology 2006;239:554-562.
28. Thoeny HC, De Keyzer F, Vandecaveye V, et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005;237:492-499.
29. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45:169-184.
30. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401-407.
31. Harris NG, Zilkha E, Houseman J, et al. The relationship between the apparent diffusion coefficient measured by magnetic resonance imaging, anoxic depolarization, and glutamate efflux during experimental cerebral ischemia. J Cereb Blood Flow Metab 2000;20:28-36.
32. Huang NC, Yongbi MN, Helpern JA. The influence of preischemic hyperglycemia on acute changes in the apparent diffusion coefficient of brain water following global ischemia in rats. Brain Res 1997;757:139-145.
33. HollingsworthKG, Lomas DJ. Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed 2006;19:231-235.
34. Ogura A, Hayakawa K, Miyati T, et al. The effect of susceptibility of gadolinium contrast media on diffusion-weighted imaging and the apparent diffusion coefficient. Acad Radiol 2008;15:867-872.
35. Chiu FY, Jao JC, Chen CY, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005;29: 176 -180.